Christopher Gottschalk
Professor; Chief, Division of General Neurology, Neurology; Director, Fellowship Program, Headache & Facial Pain Center at Yale School of Medicine
Data updated
Research Footprint
Christopher Gottschalk appears in 5 tracked papers (2015–2025), most studied alongside Psilocybin, Ayahuasca and LSD, across Headache Disorders (Cluster & Migraine), Chronic Pain and Safety & Risk Management.
Most-cited paper: Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin (133 citations).
Frequent co-authors: Emmanuelle Schindler, Brian Pittman and Deepak Cyril D’Souza.
Background & Research
Christopher Gottschalk is a neurologist and professor at Yale School of Medicine. He serves as Chief of the Division of General Neurology and Director of the Fellowship Program at the Headache & Facial Pain Center. His research interests include migraine, cluster headache, trigeminal autonomic cephalalgias, and related headache disorders, and he has coauthored multiple psilocybin studies in headache medicine.
Key Impact
He is a Yale neurologist whose clinical and research work has helped advance psychedelic studies for migraine and cluster headache.
Collaboration Network
5 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Christopher Gottschalk is associated with.